CAS 212316-86-4

Losartan Related Compound D (5-[4'-({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-1H-tetrazol-1-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt)

CAS: 212316-86-4

Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoi

Formel: C₄₄H₄₃Cl₂KN₁₂O

Farbe und Form: Powder

Molekulargewicht: 864.26969

Ref: 45-1370509

Potassium 5-[4'-[[2-Butyl-4-chloro-5-[5-[4'-[[2-Butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl]biphenyl-2-yl]tetrazol-1-yl]methyl-1H-imidazol-1-yl]methyl]biphenyl-2-yl]tetrazolide

CAS: 212316-86-4

Farbe und Form: Neat

Ref: 86-MM0168.32

N1-Losartanyl-losartan (Losartan Impurity) Potassium Salt

Kontrolliertes Produkt

CAS: 212316-86-4

Formel: C₄₄H₄₃Cl₂N₁₂O·K

Farbe und Form: Neat

Molekulargewicht: 865.90

Ref: TR-L470630

Losartan related compound D

CAS: 212316-86-4

Losartan related compound D is an antihypertensive agent that has been shown to reduce blood pressure in experimental animals. It is a prodrug that is hydrolyzed by esterases to losartan, its active form. Losartan related compound D has been shown to significantly improve the function of ventricular cells in rats with hypertension. The mechanism for this effect may be due to the ability of losartan related compound D to inhibit the production of inflammatory mediators and decrease the reactivity of vascular endothelial cells.
Losartan related compound D has not been extensively studied in humans; therefore, it is difficult to predict its effectiveness as a treatment for diseases such as heart failure or stroke.

Formel: C₄₄H₄₃Cl₂KN₁₂O

Reinheit: Min. 95%

Molekulargewicht: 865.9 g/mol

Ref: 3D-MIA31686